MassIVE MSV000082296

Complete Public PXD009548

Probing the Sensitivity of the Lumos Mass Spectrometer by analyzing varying amounts of whole cell extracts

Description

PROJECT DESCRIPTION The Orbitrap Fusion Lumos mass spectrometer has recently been shown to have better fragmentation and detection than its predecessors. Previous studies using a HeLa digest analyzed on the Lumos mass spectrometer have reported the number of peptides and proteins identified by reverse phase elution: Espadas et. al. (2017) observed an increase in detected proteins of approximately 26% when the digest concentration was increased from 100ng to 1000ng. We observed similar increases in protein identification when varying the concentration of yeast whole cell lysate. Furthermore, the concentration of starting whole cell lysate was decreased to determine the number of proteins that could be identified from as low as 5ng of whole cell lysate analyzed following a logarithmic trend. SAMPLE PROCESSING PROTOCOL Yeast (S288C) was grown overnight to an OD600=1.5 in YPD media. The cells were pelleted by centrifuging at 6000 x g for 6 minutes at 4oC. Cells were resuspended in TAP extraction buffer (40 mM HEPES-KOH, pH 7.5, 10% glycerol, 350 mM NaCl, 0.1% Tween-20, 1 mM PMSF, 0.5 mM DTT) and lysed by freezing in liquid nitrogen. Proteins were extracted by breaking the cells using a blender (Waring Commercial). Heparin (Sigma) and salt active nuclease (ArticZymes, Tromso, Norway) were added for 20 minutes at room temperature before proteins were separated from cellular material by centrifuging for 15 minutes at 4000 rpm at 4oC on a table top centrifuge (Eppendorf 5810-R). The supernatant was reserved, and the cell pellet resuspended in TAP extraction up to 6 times to extract all soluble proteins. The supernatants were pooled and further clarified by centrifuging at 14, 000 rpm for 30 minutes at 4oC using a tabletop centrifuge (Beckman Coulter Microfuge 22R). Protein content was quantitated using the Pierce BCA Protein Assay (Thermo). Protein Digestion Yeast whole cell lysate was denatured by adding 8M urea and disulfide bonds were reduced with 5 mM TCEP for 30 minutes before modifying the cysteine residues by carbamidomethylation (10 mM for 30 min in the dark). Endoproteinase Lys-C was added, and proteins digested overnight at 37oC. Urea was diluted to 2M with 100mM Tris-HCl, pH 8.5 before adding trypsin to digest overnight at 37oC. The digestion reaction was quenched by the addition of formic acid to 5%. Peptides were stored at -20oC until use. Peptide Separation Yeast whole cell extract digests were diluted to varying final concentration with buffer A (5% acetonitrile (ACN), 0.1% formic acid (FA) in water). The samples were injected in triplicate using the auto-sampler on an UltiMate 3000 liquid chromatography system (Thermo Scientific) connected inline to the Q Exactive Plus or Orbitrap Fusion Lumos Tribrid Mass Spectrometer (Thermo Scientific) fitted with the Nanospray Flex NG ion source. Peptides were trapped on a 15cm reverse phase column (5um Aqua (Phenomenex), 100um i.d.) and equilibrated with 2% buffer B (80% ACN, 0.1% FA in water) for 15 minutes at a flow rate of 300 nL/min before increasing the concentration of buffer B to 7% over 5 minutes. A linear gradient to 32% buffer B over 122 minutes was used to elute the majority of the peptides before increasing buffer B to 95% over 15 min and holding for an additional 12 minutes. The column was re-equilibrated with 2% buffer B before the next injection. Mass Spectrometry The eluted peptides were ionized for detection by the Orbitrap Fusion Lumos Tribrid Mass Spectrometer (Lumos) or Q Exactive Plus (QE+) mass spectrometer. Source conditions for both instruments were as follows: voltage, 2.5 kV, transfer tube temperature, 275oC. Peptides (MS1) were detected in the Orbitrap with the following settings: Lumos resolving power 60,000, QE+ resolving power 70,000; scan range m/z 400-1600; S-Lens RF 55%; Lumos AGC target 4.0 x 105, QE+ AGC target 1.0 x 106; microscans, 1. The top 15 peptides were selected in a data dependent mode for MS/MS fragmentation by CID at 35% NCE (Lumos) or HCD at 27% NCE (QE+) to be detected in the Orbitrap (Lumos resolving power 15,000 or QE+ resolving power 17,500) or ion trap on the Lumos with dynamic exclusion for 30s with the Lumos AGC target set to 1.0 x 104 and QE+ AGC target at 1.0 x 105. DATA PROCESSING PROTOCOL All datasets were searched with the ProLuCID search engine (v. 1.3.3) against the S. cerevisiae database downloaded from NCBI updated on May 16, 2017 with the NIST mAb sequence added as well as 160 common contaminants. The database also contained the shuffled protein sequences to estimate false discovery rates (FDRs). The result files from ProLuCID were further processed with DTASelect (v 1.9) to correlate peptide level information into protein information. Using in-house developed software, swallow, the peptide spectrum matches were maintained at FDR less than 5% for peptide and protein level matches. The datasets were compared using Contrast16 and quantitated using our in-house software NSAF7 (v 0.0.1). [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Orbitrap Lumos ; Proteomics ; Limit of Detection ; Sensitivity ; Mass Spectrometry ; Data dependent acquisition

Contact

Principal Investigators:
(in alphabetical order)
Laurence Florens, Stowers Institute for Medical Research, United States
Submitting User: mjlevy
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files Browse Results
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.